Abstract
Human papillomavirus (HPV) infections and related diseases are a major problem worldwide. The immune response to human papillomavirus infection in patients with human immunodeficiency virus (HIV) deserves special attention. HPV serves as an etiological agent and biological carcinogen for lesions and cancers associated with HPV. Currently, many possible mechanisms of escape of viruses from factors of innate and adaptive immunity are known. Despite the large amount of accumulated knowledge about the course of HIV and papillomavirus infections, early diagnosis and timely treatment of co-infected patients are difficult, which adversely affects their life prognosis. There is still a need to expand early methods for diagnosing papillomavirus infection in HIV-infected individuals and finding effective treatments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Laboratornaya i klinicheskaya meditsina. Farmatsiya
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
